All Reports and Publications

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All Reports and Publications

Most Health Centers Provide Some Behavioral Health Services to Patients With Substance Use Disorder, Despite Facing Challenges That Limit Comprehensive Treatment

Fewer than One in Five Medicare Enrollees Received Medication to Treat Their Opioid Use Disorder

Not All Medicare Enrollees Are Continuing Treatment for Opioid Use Disorder

Medicare and Medicaid Enrollees in Many High-Need Areas May Lack Access to Medications for Opioid Use Disorder

The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern

The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder in Medicare Part D Continues to Appear Low: 2022

Many Medicaid Enrollees with Opioid Use Disorder Were Treated with Medication; However, Disparities Present Concerns

The Risk of Misuse and Diversion of Buprenorphine for Opioid Use Disorder Appears to Be Low in Medicare Part D

Opioid Overdoses and the Limited Treatment of Opioid Use Disorder Continue To Be Concerns for Medicare Beneficiaries

Many Medicare Beneficiaries Are Not Receiving Medication to Treat Their Opioid Use Disorder

Concerns Persist about Opioid Overdoses and Medicare Beneficiaries' Access to Treatment and Overdose-Reversal Drugs

SAMHSA Is Missing Opportunities To Better Monitor Access to Medication Assisted Treatment Through the Buprenorphine Waiver Program

Opioid Use in Medicare Part D During the Onset of the COVID-19 Pandemic

Opioids in Medicaid: Concerns About Opioid Use Among Beneficiaries in Six Appalachian States

Few Patients Received High Amounts of Opioids from IHS-Run Pharmacies

FDA's Risk Evaluation and Mitigation Strategies: Uncertain Effectiveness in Addressing the Opioid Crisis

CMS Should Pursue Strategies To Increase the Number of At Risk Beneficiaries Acquiring Naloxone Through Medicaid

Opioid Use in Medicare Part D Continued To Decline in 2019, but Vigilance Is Needed as COVID-19 Raises New Concerns

Medicare Part D Beneficiaries at Serious Risk of Opioid Misuse or Overdose: A Closer Look

States' Use of Grant Funding for a Targeted Response to the Opioid Crisis

All Reports and Publications

Filters